HCW Biologics
HCWB · NASDAQ
$1.17−$0.06 (−4.88%)TodayMarket closed ·
Prev close $1.23
Who owns HCWB
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 17.8% of HCWB’s shares.
- Wong (Hing C)7.9%
- Jane Street Capital, L.L.C.3.3%
- Garrett (Scott T)2.6%
- Citadel Advisors LLC1.2%
- Next 6 largest institutions2.9%
- All other shareholders82.2%
| Holder | Shares | % of shares |
|---|---|---|
| Wong (Hing C) | 125.84K | 7.87% |
| Jane Street Capital, L.L.C. | 52.14K | 3.26% |
| Garrett (Scott T) | 41.64K | 2.60% |
| Citadel Advisors LLC | 19.94K | 1.25% |
| HRT Financial LP | 13.58K | 0.85% |
| Byam (Rebecca) | 9.54K | 0.60% |
| Flowers (Lee) | 8.69K | 0.54% |
| Vanguard Fiduciary Trust Co | 6.51K | 0.41% |
| Tower Research Capital LLC | 4.12K | 0.26% |
| Connective Capital Management, LLC | 3.34K | 0.21% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Extended Market Index Fund | 5.36K | 0.33% |
| Abante Quant Value, FI | 3.30K | 0.21% |
| Vanguard Extended Market Index Fund | 2.00K | 0.13% |
| Fidelity Total Market Index Fund | 121 | 0.01% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders bought $529.99K (6 trades) of HCWB on the open market, with no sales.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Wong Hing C | Buy | 23.21K | $60.00K |
| Flowers Lee | Buy | 7.74K | $20.00K |
| GARRETT SCOTT T | Buy | 7.74K | $20.00K |
| Wong Hing C | Buy | 113.88K | — |
| Wong Hing C | Buy | 113.88K | $160.00K |
| Byam Rebecca | Buy | 14.23K | — |
| Byam Rebecca | Buy | 14.23K | $20.00K |
| GARRETT SCOTT T | Buy | 177.94K | — |
| GARRETT SCOTT T | Buy | 177.94K | $250.00K |
Short interest
Settled Sep 30, 2026
- Shares short
- 60.94K
- Days to cover
- 1.00
- % of shares outstanding
- 3.81%
- Average daily volume
- 1.35M
- Change since last report
- +557.1%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.